less competition for starters.. the merged entity would really only have one major supplier (Symbion) to compete with. This will probably lead to higher prices of medications for pharmacy owners in the long run
You can be sure the ACCC will look at this very closely
Ann: Change of Director's Interest Notice, page-3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.82 |
Change
0.120(4.44%) |
Mkt cap ! $2.300B | |||
| Open | High | Low | Value | Volume |
| $2.74 | $2.93 | $2.74 | $30.66M | 10.70M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 74386 | $2.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 45951 | 36 |
View Market Depth
| Last trade - 15.39pm 28/11/2024 (20 minute delay) ? |
| SIG (ASX) Chart |
